Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 4:11 PM View:  | An2 Therapeutics, Inc. (ANTX) | 19-Nov-24 | Purchase | 5,000 | $1.01 | $5,050.00 | < 1% 524.08K to 529.08K | |
| 20-Nov-24 4:11 PM View: | An2 Therapeutics, Inc. (ANTX) | 18-Nov-24 | Private Purchase | 20,000 | $1.00 | $19,996.00 | 4% 504.08K to 524.08K | |
| 08-Feb-24 4:11 PM View: | Cyteir Therapeutics, Inc. (CYT) | 06-Feb-24 | Option Exercise | 14,150 | $1.69 | $23,913.50 | 4% 362.34K to 376.49K | |
| 19-Jan-24 7:32 PM View: | An2 Therapeutics, Inc. (ANTX) | 18-Jan-24 | Private Sale | 100,000 | $19.11 | $1,911,410.00 | (17%) 604.08K to 504.08K | |
| 08-Dec-22 5:09 PM View: | Cyteir Therapeutics, Inc. (CYT) | 07-Dec-22 | Private Purchase | 21,202 | $1.30 | $27,562.60 | 6% 341.14K to 362.34K | |
| 16-May-22 4:24 PM View: | Cyteir Therapeutics, Inc. (CYT) | 12-May-22 | Private Purchase | 743 | $1.61 | $1,196.23 | < 1% 340.39K to 341.14K | |
| 12-May-22 4:35 PM View: | Cyteir Therapeutics, Inc. (CYT) | 11-May-22 | Purchase | 1,000 | $1.70 | $1,700.00 | < 1% 339.39K to 340.39K | |
| 12-May-22 4:35 PM View: | Cyteir Therapeutics, Inc. (CYT) | 10-May-22 | Private Purchase | 49,406 | $1.89 | $93,377.30 | 17% 289.99K to 339.39K | |
| 31-Mar-22 8:15 PM View: | An2 Therapeutics, Inc. (ANTX) | 29-Mar-22 | Conversion | 98,199 | -- | -- | 100% 0 to 98.2K | |
| 01-Mar-22 5:15 PM View: | Sangamo Biosciences Inc. (SGMO) | 25-Feb-22 | Grant | 12,500 | -- | -- | 26% 48.2K to 60.7K | |
| 28-Dec-21 6:24 PM View: | Cyteir Therapeutics, Inc. (CYT) | 28-Dec-21 | Market Purchase | 601 | $9.85 | $5,919.85 | < 1% 289.39K to 289.99K | |
| 28-Dec-21 6:24 PM View: | Cyteir Therapeutics, Inc. (CYT) | 27-Dec-21 | Market Purchase | 299 | $10.04 | $3,001.82 | < 1% 289.09K to 289.39K | |
| 28-Dec-21 6:24 PM View: | Cyteir Therapeutics, Inc. (CYT) | 23-Dec-21 | Private Purchase | 200 | $9.87 | $1,974.00 | < 1% 288.89K to 289.09K | |
| 21-Dec-21 6:06 PM View: | Cyteir Therapeutics, Inc. (CYT) | 17-Dec-21 | Market Purchase | 200 | $9.88 | $1,976.00 | < 1% 288.69K to 288.89K | 11% |
| 16-Dec-21 8:01 PM View: | Amarin Corp Plc\uk (AMRN) | 15-Dec-21 | Market Purchase | 2,000 | $3.15 | $6,310.00 | 1% 194.55K to 196.55K | 3% |
| 15-Dec-21 8:09 PM View: | Cyteir Therapeutics, Inc. (CYT) | 15-Dec-21 | Market Purchase | 3,700 | $10.77 | $39,844.00 | 1% 284.99K to 288.69K | (< 1%) |
| 16-Dec-21 8:01 PM View: | Amarin Corp Plc\uk (AMRN) | 14-Dec-21 | Market Purchase | 10,000 | $3.27 | $32,689.00 | 5% 184.55K to 194.55K | (< 1%) |
| 22-Nov-21 9:12 AM View: | Acceleron Pharma Inc (XLRN) | 19-Nov-21 | Disposition (change in control) | 34,499 | -- | -- | (100%) 34.5K to 0 | |
| 24-Jun-21 8:54 PM View: | Cyteir Therapeutics, Inc. (CYT) | 22-Jun-21 | Conversion | 58,671 | -- | -- | 26% 226.32K to 284.99K | |
| 05-Apr-21 8:27 PM View: | Acceleron Pharma Inc (XLRN) | 05-Apr-21 | Option Exercise | 10,000 | $24.11 | $241,100.00 | 29% 34.5K to 44.5K | |
| 05-Apr-21 8:27 PM View: | Acceleron Pharma Inc (XLRN) | 05-Apr-21 | Market Option Sale (Planned) | 10,000 | $140.73 | $1,407,340.00 | (22%) 44.5K to 34.5K | (28%) |
| 02-Apr-21 6:08 PM View: | Acceleron Pharma Inc (XLRN) | 01-Apr-21 | Option Exercise | 10,000 | $24.11 | $241,100.00 | 29% 34.5K to 44.5K | |
| 02-Apr-21 6:08 PM View: | Acceleron Pharma Inc (XLRN) | 01-Apr-21 | Market Option Sale (Planned) | 10,000 | $134.64 | $1,346,380.00 | (22%) 44.5K to 34.5K | (33%) |
| 01-Mar-21 9:07 PM View: | Sangamo Biosciences Inc. (SGMO) | 25-Feb-21 | Grant | 8,200 | -- | -- | 20% 40.0K to 48.2K | |
| 02-Feb-21 7:00 PM View: | Acceleron Pharma Inc (XLRN) | 29-Jan-21 | Grant | 1,622 | -- | -- | 5% 32.88K to 34.5K | |
| 22-Oct-20 8:03 PM View: | Amarin Corp Plc\uk (AMRN) | 21-Oct-20 | Option Exercise | 100,000 | $3.40 | $340,000.00 | 118% 84.55K to 184.55K | |
| 20-May-20 5:22 PM View: | Sangamo Biosciences Inc. (SGMO) | 18-May-20 | Grant | 2,500 | -- | -- | 8% 30.0K to 32.5K | |
| 19-Mar-20 5:00 PM View: | Sangamo Biosciences Inc. (SGMO) | 17-Mar-20 | Market Purchase | 5,000 | $4.99 | $24,950.00 | 20% 25.0K to 30.0K | 257% |
| 13-Mar-20 5:41 PM View: | Sangamo Biosciences Inc. (SGMO) | 13-Mar-20 | Market Purchase | 5,000 | $5.67 | $28,350.00 | 25% 20.0K to 25.0K | 214% |
| 13-Mar-20 5:41 PM View: | Sangamo Biosciences Inc. (SGMO) | 12-Mar-20 | Market Purchase | 15,000 | $6.31 | $94,650.00 | 300% 5.0K to 20.0K | 182% |
| 24-Jan-20 5:59 PM View: | Acceleron Pharma Inc (XLRN) | 22-Jan-20 | Grant | 1,377 | -- | -- | 4% 31.5K to 32.88K | |
| 09-Jan-20 4:36 PM View: | Acceleron Pharma Inc (XLRN) | 07-Jan-20 | Option Exercise | 18,750 | $3.88 | $72,750.00 | 147% 12.75K to 31.5K | |
| 03-Jan-20 9:30 PM View: | Amarin Corp Plc\uk (AMRN) | 03-Jan-20 | Option Exercise | 300,000 | $3.40 | $1,020,000.00 | 355% 84.55K to 384.55K | |
| 03-Jan-20 9:30 PM View: | Amarin Corp Plc\uk (AMRN) | 03-Jan-20 | Market Option Sale | 300,000 | $20.94 | $6,282,870.00 | (78%) 384.55K to 84.55K | |
| 18-Dec-19 8:05 PM View: | Amarin Corp Plc\uk (AMRN) | 16-Dec-19 | Option Exercise | 100,000 | $9.00 | $900,000.00 | 118% 84.55K to 184.55K | |
| 18-Dec-19 8:05 PM View: | Amarin Corp Plc\uk (AMRN) | 16-Dec-19 | Market Option Sale | 100,000 | $25.83 | $2,583,380.00 | (54%) 184.55K to 84.55K | |
| 05-Jul-19 9:00 PM View: | Amarin Corp Plc\uk (AMRN) | 05-Jul-19 | Option Exercise | 100,000 | $9.00 | $900,000.00 | 118% 84.55K to 184.55K | |
| 05-Jul-19 9:00 PM View: | Amarin Corp Plc\uk (AMRN) | 05-Jul-19 | Market Option Sale | 100,000 | $23.82 | $2,381,580.00 | (54%) 184.55K to 84.55K | |
| 20-Jun-19 8:05 PM View: | Amarin Corp Plc\uk (AMRN) | 18-Jun-19 | Option Exercise | 100,000 | $3.40 | $340,000.00 | 118% 84.55K to 184.55K | |
| 20-Jun-19 8:05 PM View: | Amarin Corp Plc\uk (AMRN) | 18-Jun-19 | Market Option Sale | 100,000 | $19.02 | $1,902,090.00 | (54%) 184.55K to 84.55K | |
| 17-Jun-19 6:08 PM View: | Acceleron Pharma Inc (XLRN) | 14-Jun-19 | Market Purchase | 5,000 | $38.05 | $190,250.00 | 65% 7.75K to 12.75K | 372% |
| 12-Jun-19 5:13 PM View: | Sangamo Biosciences Inc. (SGMO) | 10-Jun-19 | Grant | 2,500 | -- | -- | 100% 2.5K to 5.0K | |
| 22-Feb-19 9:34 PM View: | Amarin Corp Plc\uk (AMRN) | 22-Feb-19 | Option Exercise | 180,625 | $8.70 | $1,572,310.00 | 214% 84.55K to 265.17K | |
| 22-Feb-19 9:34 PM View: | Amarin Corp Plc\uk (AMRN) | 22-Feb-19 | Market Option Sale | 180,625 | $19.90 | $3,594,440.00 | (68%) 265.17K to 84.55K | |
| 29-Jan-19 5:50 PM View: | Acceleron Pharma Inc (XLRN) | 25-Jan-19 | Grant | 1,250 | -- | -- | 19% 6.5K to 7.75K | |
| 11-Jan-19 8:18 PM View: | Amarin Corp Plc\uk (AMRN) | 10-Jan-19 | Option Exercise | 200,000 | $3.40 | $680,000.00 | 237% 84.55K to 284.55K | |
| 11-Jan-19 8:18 PM View: | Amarin Corp Plc\uk (AMRN) | 10-Jan-19 | Market Option Sale | 200,000 | $16.98 | $3,396,390.00 | (70%) 284.55K to 84.55K | (4%) |
| 02-Jan-19 7:54 PM View: | Amarin Corp Plc\uk (AMRN) | 02-Jan-19 | Option Exercise | 385,000 | $3.21 | $1,237,250.00 | 455% 84.55K to 469.55K | |
| 02-Jan-19 7:54 PM View: | Amarin Corp Plc\uk (AMRN) | 02-Jan-19 | Market Option Sale | 243,500 | $13.03 | $3,172,270.00 | (52%) 469.55K to 226.05K | (36%) |
| 02-Jan-19 7:54 PM View: | Amarin Corp Plc\uk (AMRN) | 02-Jan-19 | Market Sale | 141,500 | $13.03 | $1,843,430.00 | (63%) 226.05K to 84.55K | (36%) |